Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 238

The DOI matches its Crossref record.

Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future

De Clercq, Erik·2004·Chemistry & Biodiversity

Abstract

Non‐nucleoside reverse transcriptase (RT) inhibitors (NNRTIs) have become an inherent ingredient of the drug combination schemes that are currently used in the treatment of human immunodeficiency virus type 1 (HIV‐1) infections. Starting from the 1‐[(2‐hydroxyethoxy)methyl]‐6‐(phenylsulfanyl)thymine (HEPT) and 4,5,6,7‐tetrahydroimidazo[4,5,1‐jk][1,4]benzodiazepin‐2(1 H)‐one and ‐thione (TIBO) derivatives, numerous classes of compounds have been described as NNRTIs. Only three compounds have so far been approved for clinical use: nevirapine, delavirdine, and efavirenz. NNRTIs are notorious for rapidly leading to virus‐drug resistance development, primarily based on the emergence of the K103N and Y181C mutations in the HIV‐1 RT. Newer NNRTIs, such as capravirine, dapivirine (TMC 125), and DPC 083, are resilient to these ‘NNRTI’ mutations, and, therefore, offer considerable promise as future anti‐HIV‐1 drugs. NNRTIs are targeted at a specific ‘pocket’ binding site within the HIV‐1 RT, that is distinct from, but both spatially and functionally related to, the catalytic site, where the nucleoside RT inhibitors (NRTIs) and nucleotide RT inhibitors (NtRTIs) interact. NNRTIs have acquired a definitive position, as part of a combination regimen with NRTIs and NtRTIs, in the first‐line treatment of HIV‐1 infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cbdv.200490012

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
De Clercq, E.
Venue
Chemistry & Biodiversity
Publisher
Wiley
Published
2004-01
Volume
1
Issue
1
Pages
44-64
ISSN
  • 1612-1872 (ISSN-L)
  • 1612-1880
OpenAlex
W2143910776
Cited by
238
References
0
FWCI
11.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future. https://app.cochat.ai/papers/10.1002/cbdv.200490012
The paper
De Clercq, E. (2004). Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Past, Present, and Future. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.200490012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.